Palantir shares fell between 3.5% and 4.6% on Tuesday, reaching an intraday low of $179.75 before closing around $179.92. The decline followed a recent 2026 closing peak of $186.38 and came despite a September 1 U.S. Army TITAN ground station production agreement. Trading volume was 47% below typical levels, suggesting a measured retreat that likely reflected profit-taking rather than panic. Palantir’s second-quarter revenue rose 92.8% year over year to $1.94 billion, exceeding the $1.81 billion consensus, while earnings per share reached $0.41 against expectations of $0.34. The stock had climbed about 48% from pre-earnings levels but remained below its 52-week high of $207.52. Cathie Wood’s ARK Invest sold roughly 139,456 shares valued at about $26 million on August 31, continuing a broader reduction in Palantir exposure and reallocating proceeds to Block and Rocket Lab. Insiders also sold 720,166 shares worth nearly $116.8 million over the previous 90 days. Palantir trades at roughly 154 to 155 times trailing earnings, while analysts hold a $192.19 consensus target and a Moderate Buy rating. Needham, Northland Securities and Phillip Securities set targets of $215, $200 and $202, respectively. Customer numbers increased 24% to 1,049, and commercial revenue was within $45 million of government revenue. The Army agreement moves TITAN from prototypes to full production, while Pentagon-related demand approaches a $1 billion annualized run rate. Baird retained its Outperform rating and Zacks upgraded Palantir to Strong Buy. The broader market was stronger, with modest gains for the S&P 500 and Nasdaq, making Tuesday’s decline specific to Palantir.